• Evident agreed to acquire CrestOptics, triggering an exit for Primo Capital from its stake in the Rome-based microscopy technology company.
• CrestOptics makes advanced optical imaging systems for life sciences research, including spinning disk confocal microscopy and super-resolution SIM platforms.
• The business is expected to keep its research, development, and manufacturing center in Rome under the current management team.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Primo Capital Sgr Spa published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.